The Patent Finder
US

Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions

US 7,741,446 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Armagen, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Aug 20, 2027 · High confidence

Filed Aug 20, 2007 as application 11/841,623 · Granted Jun 22, 2010
Base term, 20 years from filing
Today
20 years from filing
2007 2027
Clock starts
Aug 20, 2007
Term ends
Aug 20, 2027
Granted
Jun 22, 2010
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 20, 2007, when this application, 11/841,623, was filedAug 20, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 20, 2027High confidence

This family

US 7,741,446this patent
Aug 2027
Aug 2027
US 8,753,610Lapsed on the fee record
Jun 2026
Jun 2026
US 10,144,783Term ended
Oct 2025
Oct 2025
US 11,155,631Lapsed on the fee record
Oct 2025
Oct 2025
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 16, 2008
Reel 20370, frame 760
Pardridge, William M.; Boado, Ruben J.Armagen Technologies, Inc.Assignment of Assignor's Interest
May 21, 2014
Reel 32971, frame 193
Armagen Technologies, Inc.National Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. GovernmentConfirmatory License
Feb 2, 2018
Reel 44815, frame 135
Armagen, Inc.Oxford Finance LLC, as Collateral Agent and LenderSecurity Interest
Nov 18, 2019
Reel 51042, frame 528
Oxford Finance LLCJCR Pharmaceuticals Co., Ltd.Assignment of Assignor's Interest
Apr 11, 2020
Reel 52373, frame 585
JCR Pharmaceuticals Co., Ltd.Armagen, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited